ScaleWise, the go-to-market (GTM) and talent partner for fast-scaling B2B tech companies, today announced its role in supporting BGF’s £15 million investment in Cronofy – the market-leading scheduling infrastructure platform.
As part of the investment process, BGF engaged ScaleWise to conduct a practitioner-led commercial due diligence assessment. The engagement offered insights into Cronofy’s go-to-market (GTM) capabilities and market positioning, contributing to BGF’s confidence in the company’s scalable growth potential.
Book your complimentary diagnostic consultation
ScaleWise illustrates a new standard for due diligence
Moving beyond traditional assessments to provide hands-on support, ensuring founders are equipped not just for investment, but for sustainable, scalable success post-investment.
“ScaleWise’s diagnostic approach provided us with a useful lens on the business,” said Adam Huckerby, Investor at BGF. “Their practical recommendations and commercial perspective complemented our broader diligence work and helped to validate key aspects of the growth plan.”
ScaleWise’s diagnostic-led model combines data with commercial expertise from seasoned GTM leaders who have decades of lived operational experience. Unlike traditional consulting firms, ScaleWise diagnoses GTM barriers, co-builds solutions with founders, and is actively engaged following a fundraising round to help support with the implementation of the GTM.
“Fundraising is a taxing milestone for any startup, but the real challenge is what follows,” said Tom Glason, CEO of ScaleWise.
“Our experienced approach to due diligence gave BGF and Cronofy practical support to unlock their next phase of growth. Our unique model, built by practitioners to help other practitioners, ensures we don’t just provide reports, we stay hands-on to help founders execute. We are thrilled to be part of Cronofy’s story as it pursues its mission and we look forward to working closely with its team to ensure success at this critical stage of its growth journey.”
